Opus Genetics Stock Quote IRD - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.13

Bid

1.01

Ask

1.18

Volume

174

0.00 Day's Range 0.00

0.81 52 Week Range 1.56

Market Cap

35.672M

Previous Close

1.13

Open

Last Trade

1.03

Last Trade Time

08:52:23

Financial Volume

VWAP

Average Volume (3m)

207,638

Shares Outstanding

31,568,457

Dividend Yield

PE Ratio

-5.72

Earnings Per Share (EPS)

-0.32

Revenue

19.05M

Net Profit

-9.99M

Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol ... Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema. Show more

Sector

Motion Pic, Videotape Prodtn

Industry

Pharmaceutical Preparations

Website

www.ocuphire.com

Headquarters

Wilmington, Delaware, USA

Founded

1999

Opus Genetics Inc is listed in the Motion Pic, Videotape Prodtn sector of the NASDAQ with ticker IRD. The last closing price for Opus Genetics was $1.13. Over the last year, Opus Genetics shares have traded in a share price range of $ 0.81 to $ 1.56.

Opus Genetics currently has 31,568,457 shares outstanding. The market capitalization of Opus Genetics is $35.67 million. Opus Genetics has a price to earnings ratio (PE ratio) of -5.72.

Restore Value Slate Led by Mina Sooch Files Preliminary Proxy Materials for the Election of Six Highly Qualified Directors at the 2025 Annual Meeting of Opus Genetics

Believes that Current Board’s Strategic, Management and Capital Allocation Failures have Resulted in Stockholder Value Destruction Highlights...

Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.

Current Board’s Strategic, Management, and Capital Allocation Failures Have Driven an 80% Stock Decline Over Last 22 Months New Leadership is...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.01	0.892857142857	1.12	1.29	0.9602	549744	1.1795462	CS
4	0.0688	6.483226536	1.0612	1.29	0.878	263099	1.11241122	CS
12	-0.0894	-7.33147449565	1.2194	1.56	0.878	207638	1.16109703	CS
26	-0.06	-5.04201680672	1.19	1.56	0.81	217943	1.11528754	CS
52	-0.06	-5.04201680672	1.19	1.56	0.81	217943	1.11528754	CS
156	-0.06	-5.04201680672	1.19	1.56	0.81	217943	1.11528754	CS
260	-0.06	-5.04201680672	1.19	1.56	0.81	217943	1.11528754	CS

IRD - Frequently Asked Questions (FAQ)

What is the current Opus Genetics share price?

The current share price of Opus Genetics is $ 1.13

How many Opus Genetics shares are in issue?

Opus Genetics has 31,568,457 shares in issue

What is the market cap of Opus Genetics?

The market capitalisation of Opus Genetics is USD 35.67M

What is the 1 year trading range for Opus Genetics share price?

Opus Genetics has traded in the range of $ 0.81 to $ 1.56 during the past year

What is the PE ratio of Opus Genetics?

The price to earnings ratio of Opus Genetics is -5.72

What is the cash to sales ratio of Opus Genetics?

The cash to sales ratio of Opus Genetics is 3

What is the reporting currency for Opus Genetics?

Opus Genetics reports financial results in USD

What is the latest annual turnover for Opus Genetics?

The latest annual turnover of Opus Genetics is USD 19.05M

What is the latest annual profit for Opus Genetics?

The latest annual profit of Opus Genetics is USD -9.99M

What is the registered address of Opus Genetics?

The registered address for Opus Genetics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Opus Genetics website address?

The website address for Opus Genetics is www.ocuphire.com

Which industry sector does Opus Genetics operate in?

Opus Genetics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OSRHOSR Holdings Inc	$ 4.29 (168.13%)	36.59M
PTPIPetros Pharmaceuticals Inc	$ 0.1228 (112.46%)	290.58M
SURGSurgePays Inc	$ 2.51 (81.88%)	18.29M
OMCCOld Market Capital Corporation	$ 10.16 (61.14%)	45
LIVELive Ventures Inc	$ 11.13 (59.00%)	13
RAASMI 3Fourteen REAL Asset Allocation ETF	$ 10.01 (-59.31%)	8
TRDAEntrada Therapeutics Inc	$ 6.01 (-40.93%)	3
ACONAclarion Inc	$ 0.5101 (-31.71%)	2.06M
VGSRVert Global Sustainable Real Estate ETF	$ 7.01 (-31.34%)	1
HLMNHillman Solutions Corporation	$ 6.21 (-31.23%)	19
PTPIPetros Pharmaceuticals Inc	$ 0.1236 (113.84%)	290.59M
OCEAOcean Biomedical Inc	$ 0.0769 (35.39%)	132.68M
LYTLytus Technologies Holdings PTV Ltd	$ 0.0572 (13.04%)	104.52M
DGLYDigital Ally Inc	$ 0.0368 (2.22%)	43.13M
OSRHOSR Holdings Inc	$ 4.29 (168.13%)	36.59M